Sarcopenia, characterized by a progressive loss of skeletal muscle mass and strength that occurs with advancing age, has been associated with falls, fracture, disability, and mortality. Depending on the definitions used, the prevalence in 60-to 80-year old population is reported as 0.9%-35.9%, while the prevalence ranges from 7%-70.0% in people older than 80 years. Sarcopenia has been associated with lower quality of life. Well-designed exercise interventions, particularly resistance training as well as nutritional supplementation, have been proved to improve muscle strength and performance in geriatric populations. Resistance training may also enhance quality of life. However, there are limited data on the effects of nutritional supplementation as an intervention on quality of life among individuals with sarcopenia. This review briefly summarizes the relationship between sarcopenia and quality of life and presents the potential of interventions to improve muscle quality, physical performance, and quality of life. ACADEMIC EDITOR: atsushi sakuraba, editor in Chief PEER REVIEW: three peer reviewers contributed to the peer review report. Reviewers' reports totaled 497 words, excluding any confidential comments to the academic editor.FUNDING: authors disclose no external funding sources.
COMPETING INTERESTS: Authors disclose no potential conflicts of interest.COPYRIGHT: © the authors, publisher and licensee libertas academica limited.this is an open-access article distributed under the terms of the Creative Commons CC-BY-nC 3.0 license.
CORRESPONDENCE: rubyyu@cuhk.edu.hkPaper subject to independent expert single-blind peer review. all editorial decisions made by independent academic editor. Upon submission manuscript was subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to human and animal study participants, and compliance with any copyright requirements of third parties. this journal is a member of the Committee on Publication ethics (COPe).Provenance: the authors were invited to submit this paper.Published by libertas academica. learn more about this journal.
SarcopeniaSarcopenia, defined as a geriatric syndrome characterized by a progressive loss of skeletal muscle mass and strength that occurs with advancing age, was first introduced by Rosenberg in 1989.1,2 The decline in muscle mass occurs after the age of 30 years.3,4 After the age of 50 years, muscle mass is reported to decline at an annual rate of approximately 0.2%; 5 after 70 years, the decline may accelerate to 0.6%-1% per year. [6][7][8] Over the past few decades, refining the definition of sarcopenia has led to significant variation in the meaning. Initially, the definition consists of the measurement of appendicular mass divided...